Skip to content

Study on the efficacy and safety of total hip arthroplasty for high dislocation of the hip

Study on the efficacy and safety of total hip arthroplasty for high dislocation of the hip

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060030
Enrollment
Unknown
Registered
2022-05-15
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developmental dysplasia of the hip

Interventions

Treatment group:total hip arthroplasty

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years, no gender limit; 2. Patients with DDH who underwent THA between January 1, 2004 and May 1, 2021; 3. DDH patients diagnosed as Crowe III and IV by preoperative pelvic radiography; 4. THA has been performed for more than 1 year.

Exclusion criteria

Exclusion criteria: 1. Incomplete image data; 2. No regular review after surgery.

Design outcomes

Primary

MeasureTime frame
Harris hip function score;Visual analogue scale score;Short form health survey (SF-36);NAHS scores;International hip outcomes instrument score -iHOT-12;TILT angle;COBB angle;Distance from pubic symphysis to coccyx tip;Forward inclination angle;Abduction angle;Bone coverage rate;Truncated osteotomy;Limb length difference;Limb lengthening ratio;Gait analysis;Surface electromyography;Hemoglobin change;Drainage volume of drainage tube;Fracture;Dislocation;Infection;Renovation;

Secondary

MeasureTime frame
Prosthesis size;Prosthesis type;Operation time;Bleeding volume;

Countries

China

Contacts

Public ContactChen Guangxing
cgx7676@hotmail.com+86 18623108787

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026